ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P TSX Capped Composite...
32.63
(
1.02%
)
US Tech 100
15,626.00
(
0.47%
)
S&P 500
4,594.63
(
0.59%
)
US Dollar vs CAD
1.34975
(
0.0%
)
Bitcoin
38,800.82
(
0.25%
)
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Adial Pharmaceuticals Inc (ADIL)

  7. Adial Pharmaceuticals Inc (ADIL) News

ADIL Adial Pharmaceuticals Inc

2.02
-0.17 (-7.76%)
Dec 01 2023 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Adial Pharmaceuticals Inc ADIL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.17 -7.76% 2.02 18:57:19
Open Price Low Price High Price Close Price Previous Close
2.10 1.88 2.4299 1.9101 2.19
more quote information »

Recent News

Date Time Source Heading
11/29/202315:47EDGAR2Form 8-K - Current report
11/29/202315:05GLOBEAdial Pharmaceuticals Regains Compliance with Nasdaq Listing..
11/28/202315:10EDGAR2Form 8-K - Current report
11/24/202308:24EDGAR2Form PRE 14A - Other preliminary proxy statements
11/20/202306:46EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/19/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
11/14/202316:02GLOBEAdial Pharmaceuticals Reports Third Quarter 2023 Financial..
11/08/202315:05EDGAR2Form S-1 - General form for registration of securities under..
11/06/202305:14EDGAR2Form 8-K - Current report
10/31/202307:30GLOBEAdial Pharmaceuticals Chief Medical Officer and Key Opinion..
10/30/202316:24EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
10/30/202316:18EDGAR2Form 8-K/A - Current report: [Amend]
10/30/202316:17EDGAR2Form NT 10-Q/A - Notification of inability to timely file..
10/25/202307:00GLOBEAddiction Experts Highlight the Need for..
10/24/202315:48EDGAR2Form 8-K - Current report
10/24/202315:30GLOBEAdial Pharmaceuticals Announces Closing of $4 Million..
10/20/202307:00GLOBEAdial Pharmaceuticals Announces $4 Million Private Placement..
10/19/202309:30GLOBEAdial Pharmaceuticals Awarded Notice of Allowance for Key..
10/18/202307:00GLOBEAdial Pharmaceuticals Wins Frost & Sullivan's 2023 North..
10/03/202307:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/28/202306:00GLOBEAdial Pharmaceuticals to Host a Virtual Key Opinion Leader..
9/26/202320:08EDGAR2Form 8-K - Current report
9/21/202315:10EDGAR2Form 8-K - Current report
9/11/202305:03EDGAR2Form 8-K - Current report
9/05/202307:30GLOBEAdial Pharmaceuticals to Present at the H.C. Wainwright 25th..
8/28/202307:30GLOBEAdial Pharmaceuticals Chief Medical Officer and Key Opinion..
8/23/202307:45EDGAR2Form 8-K - Current report
8/23/202307:30GLOBEAdial Pharmaceuticals Regains Compliance with Nasdaq Listing..
8/21/202307:46EDGAR2Form 8-K - Current report
8/21/202307:30GLOBEAdial Pharmaceuticals Reports Second Quarter 2023 Financial..
8/21/202307:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/18/202316:05EDGAR2Form 8-K - Current report
8/15/202305:01EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
8/04/202307:30EDGAR2Form 8-K - Current report
8/04/202307:30GLOBEAdial Pharmaceuticals Announces Reverse Stock Split to..
7/13/202315:39EDGAR2Form S-1/A - General form for registration of securities..
7/11/202307:30GLOBEAdial Provides Business Update Following Favorable Comments..
7/10/202316:17EDGAR2Form 8-K - Current report
6/01/202308:00GLOBEAdial Pharmaceuticals to Present at the 2023 Jefferies..
5/12/202307:30GLOBEAdial Pharmaceuticals Reports First Quarter 2023 Financial..
5/10/202307:30GLOBEAdial Pharmaceuticals Receives Notice of Exercise from..
3/30/202315:05GLOBEAdial Pharmaceuticals Reports 2022 Fiscal Year Financial..
3/21/202308:00GLOBEAdial Pharmaceuticals Engages The Keswick Group to Advance..
3/08/202308:00GLOBEAdial Pharmaceuticals to Present at the 35th Annual Roth..
3/07/202308:10APSBiotech Is Red Hot During Tuesday's Premarket Hours
3/06/202315:19GLOBEAdial Pharmaceuticals Provides Update on Regulatory Strategy..
3/02/202308:00GLOBEAdial Pharmaceuticals Schedules Business Update Conference..
2/27/202308:00GLOBEAdial Pharmaceuticals Announces Closing of $0.75..
2/24/202306:00GLOBEAdial Pharmaceuticals Announces Pricing of $0.75 Million..
2/21/202308:00GLOBEAdial Pharmaceuticals Confirms Scheduling of Meetings with..

Your Recent History

NASDAQ
ADIL
Adial Pharmaceuticals
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com